Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Trading Down 0.2%

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)’s share price was down 0.2% during trading on Wednesday . The company traded as low as $18.93 and last traded at $18.93. Approximately 9,127 shares changed hands during mid-day trading, an increase of 31% from the average daily volume of 6,984 shares. The stock had previously closed at $18.96.

Invesco Nasdaq Biotechnology ETF Stock Performance

The company has a 50 day moving average price of $19.48 and a two-hundred day moving average price of $20.26. The firm has a market capitalization of $15.95 million, a price-to-earnings ratio of 16.48 and a beta of 0.61.

Invesco Nasdaq Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 22nd. Shareholders of record on Tuesday, September 19th were issued a dividend of $0.0412 per share. This represents a $0.16 annualized dividend and a yield of 0.87%. The ex-dividend date of this dividend was Monday, September 18th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. UBS Group AG raised its holdings in shares of Invesco Nasdaq Biotechnology ETF by 259.3% during the first quarter. UBS Group AG now owns 1,254 shares of the company’s stock valued at $26,000 after acquiring an additional 905 shares during the last quarter. Tower Research Capital LLC TRC raised its position in shares of Invesco Nasdaq Biotechnology ETF by 18.4% in the first quarter. Tower Research Capital LLC TRC now owns 16,824 shares of the company’s stock valued at $348,000 after buying an additional 2,618 shares during the last quarter. Bank of America Corp DE lifted its stake in shares of Invesco Nasdaq Biotechnology ETF by 26.6% in the fourth quarter. Bank of America Corp DE now owns 17,931 shares of the company’s stock worth $378,000 after buying an additional 3,765 shares in the last quarter. Partners Capital Investment Group LLP boosted its position in Invesco Nasdaq Biotechnology ETF by 100.4% during the second quarter. Partners Capital Investment Group LLP now owns 25,717 shares of the company’s stock worth $525,000 after acquiring an additional 12,887 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in Invesco Nasdaq Biotechnology ETF by 66.1% during the 2nd quarter. Tower Research Capital LLC TRC now owns 27,946 shares of the company’s stock valued at $571,000 after acquiring an additional 11,122 shares in the last quarter.

Invesco Nasdaq Biotechnology ETF Company Profile

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.